To evaluate the individual and combined performances of the Ovarian‐adnexal Reporting and Data System Ultrasound (O‐RADS US) and serum cancer antigen 125 (CA‐125) in assessing adnexal malignancy risk in women… Click to show full abstract
To evaluate the individual and combined performances of the Ovarian‐adnexal Reporting and Data System Ultrasound (O‐RADS US) and serum cancer antigen 125 (CA‐125) in assessing adnexal malignancy risk in women with different menopausal status.
               
Click one of the above tabs to view related content.